The Putative Impact of the SARS-CoV-2 induced Covid 19 on Cancer Patients
Main Article Content
Abstract
The term cancer is given to the condition that is represented by the emergence of a group of diseases or health problems as a result of the abnormal growth of some cells of the body, so that these cells divide in a way that the body cannot control, and it is possible for these cells to spread to reach healthy cells, causing damage and destroying them, and the cells Cancer continues to grow and spread, it may spread in one of two ways; Either by direct spread or metastasis, which is the transfer of cancer cells through blood vessels or lymphatic vessels, and may form tumors in the new areas that it has reached. To date, there is limited evidence that any cancer treatment may increase your odds of contracting COVID-19 more than anyone else exposed to the virus. But there is some evidence that if cancer patients become infected with Covid-19, they may be more seriously affected, likely because cancer and cancer treatment can contribute to a weakening of the immune system, which may reduce the ability to fight infection. The aim of this descriptive minireview, generally, is to shed light on The Putative Impact of the SARS-CoV-2 induced Covid 19 on Cancer Patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Centers for Disease Control and Prevention (CDC). Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. Updated October 6, 2020. Accessed August 14, 2020.
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html
II. Richards, M. et al. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer 1, 565–567 (2020).
III. Wang Q, Berger NA, Xu R. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncol. 2021;7(2):220–227.
doi:10.1001/jamaoncol.2020.6178
IV. American Cancer Society. Why people with cancer are more likely to get infections. Published March 2020. Accessed August 14, 2020.
V. Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904-913. doi:10.1016/S1470-2045(20)30310-7
VI. Kuderer NM, Choueiri TK, Shah DP, et al; COVID-19 and Cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907-1918. doi:10.1016/S0140-6736(20)31187-9
VII. Rivera DR, Peters S, Panagiotou OA, et al; COVID-19 and Cancer Consortium. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study. Cancer Discov. 2020;CD-20-CD-0941.PubMedGoogle Scholar
VIII. Robilotti EV, Babady NE, Mead PA, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020; 26(8):1218-1223. doi:10.1038/s41591-020-0979-0
IX. National Cancer Institute (NCI). Common cancer types. Updated September 25, 2020. Accessed June 28, 2020. https://www.cancer.gov/types/common-cancers